Harry Welten, previously chief financial officer of Nitec Pharma AG, has been named CFO of Cytos Biotechnology Ltd in Switzerland, effective 1 June 2010. Mr Welten was CFO at Nitec during the Swiss company’s merger with Horizon Therapeutics, Inc earlier this year. He will succeed Jakob Schlapbach, who is taking early retirement. Cytos is developing immunotherapies for chronic diseases.
Copyright 2010 Evernow Publishing Ltd